Adverse events associated with statin co-use in breast cancer patients: a disproportionality analysis based on the FDA Adverse Event Reporting System
Therapeutic Advances in Drug Safety
Published online on May 22, 2026
Abstract
Therapeutic Advances in Drug Safety, Volume 17, January-December 2026.
Background:An increasing number of breast cancer patients are using statins concomitantly. However, there are relatively few safety studies on the association between statins and adverse events (AEs) during breast cancer treatment.Objective:This study ...
Background:An increasing number of breast cancer patients are using statins concomitantly. However, there are relatively few safety studies on the association between statins and adverse events (AEs) during breast cancer treatment.Objective:This study ...